Solace Therapeutics
Framingham
About Solace Therapeutics
Solace Therapeutics is a medical device company that develops and commercializes non-surgical office-based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). It is dedicated to improving the patient’s quality of life by eliminating side effects typically associated with current drug and surgical therapies. The company offers a technology that is designed to offer patients an office-based therapy that does not require anesthesia or surgery, no lifestyle change required, before or after treatment, and reversible at any time.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $36.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2020)
- Website: solacetx.com
- Phone: (508)283-1200
Industries & Categories
Health Care, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/solace-therapeutics-68097 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.